Cargando…
Pharmacologic Interventions for Fracture Risk Reduction in the Oldest Old: What Is the Evidence?
With an increasingly older population, the proportion of patients 85 years or older seeking interventions to protect their musculoskeletal health is growing. Osteoporosis in the geriatric population presents unique diagnostic and therapeutic challenges. Multimorbidity, frailty, falls, polypharmacy,...
Autores principales: | Sfeir, Jad G, Pignolo, Robert J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520064/ https://www.ncbi.nlm.nih.gov/pubmed/34693190 http://dx.doi.org/10.1002/jbm4.10538 |
Ejemplares similares
-
Cognitive Decline and Dementia in the Oldest-Old
por: Kravitz, Efrat, et al.
Publicado: (2012) -
Pharmacological treatment of osteoporosis in the oldest old
por: Vandenbroucke, A, et al.
Publicado: (2017) -
What matters for life satisfaction among the oldest-old? Evidence from China
por: Ng, Sor Tho, et al.
Publicado: (2017) -
Effects of an Evidence-Based Falls Risk-Reduction Program on Physical Activity and Falls Efficacy among Oldest-Old Adults
por: Cho, Jinmyoung, et al.
Publicado: (2015) -
What have we learned from cognition in the oldest-old
por: Kawas, Claudia H., et al.
Publicado: (2021)